Signal sequence is still required in genes downstream of "autocleaving" 2A peptide for secretary or membrane-anchored expression

Analytical Biochemistry

Volumn 399, Issue 1, 2010, Pages 144-146

  Yan, Jun ^a   Wang, Hongjun ^b   Xu, Qian ^c   Jain, Nidhi ^b   Toxavidis, Vasilis ^b   Tigges, John ^b   Yang, Hailin ^d   Yue, Guohua ^d   Gao, Wenda ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRANDEIS UNIVERSITY   (United States)

^d Antagen Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; MAMMALS;

2A PEPTIDE; CELL SURFACES; EXPRESSION VECTORS; MAMMALIAN CELLS; MAMMALIAN ENDOPLASMIC RETICULUM; SIGNAL SEQUENCE;

PEPTIDES;

2A PEPTIDE; HYGROMYCIN B; IMMUNOGLOBULIN G1; INTERLEUKIN 2; PEPTIDE; THY 1 ANTIGEN; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURFACE; CHO CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; FLOW CYTOMETRY; MEMBRANE BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION;

MAMMALIA;

EID: 77649185791     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.11.032     Document Type: Article

References (13)

1. de Felipe P. Polycistronic viral vectors. Curr. Gene Ther. 2002, 2:355-378.
2. Ngoi S.M., Chien A.C., Lee C.G. Exploiting internal ribosome entry sites in gene therapy vector design. Curr. Gene Ther. 2004, 4:15-31.
3. Mizuguchi H., Xu Z., Ishii-Watabe A., Uchida E., Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 2000, 1:376-382.
4. Zhou Y., Aran J., Gottesman M.M., Pastan I. Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector. Hum. Gene Ther. 1998, 9:287-293.
5. Szymczak A.L., Vignali D.A. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin. Biol. Ther. 2005, 5:627-638.
6. de Felipe P., Hughes L.E., Ryan M.D., Brown J.D. Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. J. Biol. Chem. 2003, 278:11441-11448.
7. Ryan M.D., King A.M., Thomas G.P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 1991, 72:2727-2732.
8. Chinnasamy D., Milsom M.D., Shaffer J., Neuenfeldt J., Shaaban A.F., Margison G.P., Fairbairn L.J., Chinnasamy N. Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI. Virol. J. 2006, 3:14.
9. Szymczak A.L., Workman C.J., Wang Y., Vignali K.M., Dilioglou S., Vanin E.F., Vignali D.A. Correction of multi-gene deficiency in vivo using a single "self-cleaving" 2A peptide-based retroviral vector. Nat. Biotechnol. 2004, 22:589-594.
10. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignali D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
11. Fang J., Qian J.J., Yi S., Harding T.C., Tu G.H., VanRoey M., Jooss K. Stable antibody expression at therapeutic levels using the 2A peptide. Nat. Biotechnol. 2005, 23:584-590.
12. de Felipe P., Ryan M.D. Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 2004, 5:616-626.
13. Barash S., Wang W., Shi Y. Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem. Biophys. Res. Commun. 2002, 294:835-842.